GLP-1 medications treat type 2 diabetes and assist in weight management
Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, showed up to 24.2% body weight reduction in Phase 2 trials
Your age, health, habits, and biology all shape the response
Are ready to pair FDA-approved medications with sustainable nutrition and activity changes that match your routines in Lawrenceville
Common Side Effects The most common side effects are nausea, bloating, vomiting, diarrhea, constipation, and early fullness
TB-500 binds monomeric G-actin via the LKKTETQ motif, modulating the actin pool available for cytoskeletal remodeling and cell migration